首页 正文

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial

{{output}}
Background&aims: Evidence for primary prophylaxis of spontaneous bacterial peritonitis (SBP) is weak and the selection of quinolone-resistant bacteria is currently of concern. Here we present results from a randomized, double-bli... ...